This helps your body readjust to the medication while minimizing side effects
Summary: Microdosing GLP-1 for Hashimoto's is an unapproved, off-label practice lacking clinical evidence, and the NHS does not recommend GLP-1 receptor agonists for thyroid conditions without concurrent type 2 diabetes or obesity meeting specific criteria
Clinical studies have shown that weight regain can occur after stopping semaglutide or tirzepatide, along with some reversal of cardiometabolic improvements
The generic name for Ozempic is semaglutide, and when patients take it for weight loss, its called Wegovy
While this rapid initial loss is partly water weight and glycogen depletion, the metabolic signal to the body is the same
You can also explore more on what Retatrutide does to get a broader picture of how this medication works before committing to a plan